High materiality8/10
Mirum Pharmaceuticals price target raised to $130 from $123 at Baird
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Analyst target update: MIRM target raised to $130 at Baird; current price $87.96.
- Target raised to $130 by Baird
- Current price: $87.96
- Analyst firm: Robert W. Baird
Key facts
- 01
Target: $130
- 02
Posted price: $87.96
- 03
Analyst firm: Robert W. Baird
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.